MedTrace Logo

Prediction of Risk of Hypotension in Hemodialysis

NCT03350308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-12-12

No results posted yet for this study

Summary

The main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration. The secondary objective is to study the impact of dysfunction in the mechanisms of compensation for decreased blood volume (heart disease, neuropathy, drugs) on the risk of intradialytic hypotension.

Conditions

  • Chronical Kidney Disease
  • Hypotension
  • Residual Blood Volume
  • Hemodialysis

Interventions

OTHER

hemodialysis

The main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration

Sponsors & Collaborators

  • Fresenius Medical Care North America

    collaborator INDUSTRY

  • Centre de dialyse AURA Plaisance

    collaborator UNKNOWN

  • Pôle Santé République

    collaborator OTHER

  • Service de Néphrologie et Hémodialyse

    collaborator UNKNOWN

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Julien ANIORT · University Hospital, Clermont-Ferrand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2023-12-27
Completion
2023-12-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03350308 on ClinicalTrials.gov